세계의 철 결핍성 빈혈 시장 보고서(2025년)

Iron Deficiency Anemia Global Market Report 2025

US $ 4,490 ￦ 6,253,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,039,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,824,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

철 결핍성 빈혈 시장 규모는 향후 수년간 강력한 성장이 예상될 전망입니다. 예측 기간의 성장은 여성 건강에 대한 집중도 증가, 최소 침습적 치료법에 대한 수요 증가, 일반의약품의 가용성 증가, 유통망 확장, 개인 맞춤형 의약품 채택 증가 등에 의해 주도될 것으로 예상됩니다. 주요 동향으로는 혁신적인 약물전달 시스템의 개발, 진단 툴이나 모니터링 기기의 진보, 병용 요법의 출현, 드러그 딜리버리에 있어서의 나노 기술의 통합 등을 들 수 있습니다.

영양 결핍증의 유병률 증가는 철 결핍성 빈혈 시장의 성장을 가속할 것으로 예측됩니다. 저소득층의 식량 불안 등이 영양 부족의 사례 증가의 원인이 되고 있습니다. National Health Services는 영국의 영양 결핍증으로 인한 입원 환자 수가 2021/22년 25만 명에서 2022/23년에는 50만 명으로 두 배로 증가했다고 보고했습니다.

철 결핍성 빈혈 시장의 주요 기업은 영양 흡수를 향상시키고, 내성을 개선하고, 철 결핍증에 효과적으로 대처하기 위한 철제 정맥 주사와 같은 혁신적인 솔루션의 개발에 주력하고 있습니다. 예를 들어, 2024년 3월 인도에 본사를 둔 제약 회사 Cadila Pharmaceuticals는 철 결핍성 빈혈(IDA)의 치료를 위해 카르복시말토스 철을 배합한 철 주사제 Redshot FCM을 출시했습니다. FCM은 성인과 1세 이상의 소아를 대상으로 설계되어 있어, 1회 투여로 고용량의 철 주입이 가능하고, 안전성이 높고, 아나필락시스의 위험도 최소한으로 억제되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 철 결핍성 빈혈 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 철 결핍성 빈혈 시장 : 성장률 분석
• 세계의 철 결핍성 빈혈 시장 실적: 규모와 성장, 2019-2024년
• 세계의 철 결핍성 빈혈 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 철 결핍성 빈혈 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 철 결핍성 빈혈 시장 : 치료 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 경구 철요법
• 비경구 철요법
• 적혈구 수혈
• 세계의 철 결핍성 빈혈 시장 : 유통 채널별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 병원 약국
• 약국과 약국
• 온라인 약국
• 세계의 철 결핍성 빈혈 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 병원
• 클리닉
• 재택치료
• 세계의 철 결핍성 빈혈 시장 : 경구 철 요법의별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 황산제일철
• 글루콘산 제일철
• 푸마르산 제일철
• 다당류-철 복합체
• 카르보닐철
• 세계의 철 결핍성 빈혈 시장 : 비경구 철제 요법별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 철 수크로스
• 카르복시 말토스 제2철
• 철 덱스트란
• 페르목시톨
• 글루콘산철
• 세계의 철 결핍성 빈혈 시장 : 적혈구 수혈별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 백혈구 제거 적혈구 수혈
• 세척 적혈구 수혈
• 방사선 조사 적혈구 수혈

제7장 지역별/국가별 분석

• 세계의 철 결핍성 빈혈 시장 :지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 철 결핍성 빈혈 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 철 결핍성 빈혈 시장 : 경쟁 구도
• 철 결핍성 빈혈 시장 : 기업 프로파일
  • AbbVie Inc.
  • Sanofi SA
  • Abbott Laboratories
  • Fresenius SE & Co. KGaA
  • Sandoz International GmbH

제31장 기타 주요 기업 및 혁신 기업

• CSL Limited
• Daiichi Sankyo Company Limited
• Perrigo Company
• Cipla Limited
• Dr. Reddy's Laboratories Limited
• Cadila Healthcare Limited
• Zydus Cadila
• Lupin Limited
• Alkem Laboratories Limited
• AMAG Pharmaceuticals Inc.
• Akebia Therapeutics Inc.
• Rockwell Medical Inc.
• Pharmacosmos A/S
• Shield Therapeutics plc
• AdvaCare Pharma LLC

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

• 철 결핍성 빈혈 시장, 2029년 : 새로운 기회를 제공하는 국가
• 철 결핍성 빈혈 시장, 2029년 : 새로운 기회를 제공하는 부문
• 철 결핍성 빈혈 시장, 2029년 : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제36장 부록

SHW

영문 목차

영문목차

Iron deficiency anemia is a condition characterized by insufficient iron levels in the body, leading to inadequate production of hemoglobin, the protein in red blood cells responsible for oxygen transport. This deficiency can result from inadequate dietary intake, poor iron absorption, blood loss, or increased iron requirements, such as during pregnancy.

The primary treatment options for iron deficiency anemia include oral iron therapy, parenteral iron therapy, and red blood cell transfusion. Oral iron therapy involves the intake of iron supplements in the form of tablets, capsules, or liquids to restore iron levels in the body. These treatments are distributed through hospital pharmacies, drug stores, retail pharmacies, and online pharmacies, serving end users such as hospitals, clinics, and home healthcare providers.

The iron deficiency anemia market research report is one of a series of new reports from The Business Research Company that provides iron deficiency anemia market statistics, including iron deficiency anemia industry global market size, regional shares, competitors with an iron deficiency anemia market share, detailed iron deficiency anemia market segments, market trends and opportunities, and any further data you may need to thrive in the iron deficiency anemia industry. This iron deficiency anemia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The iron deficiency anemia market size has grown strongly in recent years. It will grow from $3.37 billion in 2024 to $3.58 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period was driven by initiatives from non-government organizations, a rising prevalence of chronic disorders, increased focus on parental care, awareness campaigns addressing nutritional deficiencies, and the expansion of telemedicine services.

The iron deficiency anemia market size is expected to see strong growth in the next few years. It will grow to $4.55 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period is expected to be driven by an increasing focus on women's health, rising demand for minimally invasive therapies, greater availability of over-the-counter products, the expansion of distribution networks, and the growing adoption of personalized medicine. Key trends include the development of innovative drug delivery systems, advancements in diagnostic tools and monitoring devices, the emergence of combination therapies, and the integration of nanotechnology in drug delivery.

The rising prevalence of nutritional deficiencies is expected to drive the growth of the iron deficiency anemia market. Nutritional deficiency occurs when the body lacks essential nutrients such as vitamins, minerals, proteins, or fats necessary for optimal health. Poor dietary choices, the widespread consumption of processed foods, and food insecurity, particularly in lower-income populations, contribute to the increasing cases of nutritional deficiencies. Iron deficiency anemia is a common nutritional disorder in which inadequate iron intake reduces red blood cell production, impairing the body's oxygen transport capacity. For example, in December 2023, the National Health Services, a UK-based government department, reported that total hospital admissions for nutritional deficiencies in the United Kingdom doubled from 250,000 in 2021/22 to 500,000 in 2022/23. This increasing trend highlights the growing demand for iron deficiency anemia treatments.

Leading companies in the iron deficiency anemia market are focused on developing innovative solutions, such as intravenous iron injections, to enhance nutrient absorption, improve tolerance, and effectively address iron deficiency. Intravenous iron injections deliver iron directly into the bloodstream, offering a solution for patients who cannot tolerate or adequately absorb oral iron supplements. For instance, in March 2024, Cadila Pharmaceuticals, an India-based pharmaceutical company, introduced Redshot FCM, an intravenous iron injection formulated with ferric carboxymaltose for the treatment of iron deficiency anemia (IDA). Designed for both adults and children over one year old, Redshot FCM provides a high-dose iron infusion in a single session with a strong safety profile and minimal risk of anaphylaxis. This treatment is particularly beneficial for vulnerable populations such as pregnant women, elderly individuals, and cancer patients, offering a rapid improvement in hemoglobin levels.

In August 2022, CSL Limited, an Australia-based biotechnology company, acquired Vifor Pharma AG for $11.7 billion. This acquisition aims to position CSL Limited as a global leader in iron deficiency, nephrology, and cardio-renal therapies. By integrating Vifor Pharma's expertise, CSL expands its portfolio, strengthens its presence in high-growth markets, and enhances its focus on patient-centered care while achieving both immediate earnings growth and long-term sustainability. Vifor Pharma AG, a Switzerland-based company, is a key player in the treatment of iron deficiency and iron deficiency anemia.

Major players in the iron deficiency anemia market are AbbVie Inc., Sanofi S.A., Abbott Laboratories, Fresenius SE & Co. KGaA, Sandoz International GmbH, CSL Limited, Daiichi Sankyo Company Limited, Perrigo Company, Cipla Limited, Dr. Reddy's Laboratories Limited, Cadila Healthcare Limited, Zydus Cadila, Lupin Limited, Alkem Laboratories Limited, AMAG Pharmaceuticals Inc., Akebia Therapeutics Inc., Rockwell Medical Inc., Pharmacosmos A/S, Shield Therapeutics plc, AdvaCare Pharma LLC.

North America was the largest region in the iron deficiency anemia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in iron deficiency anemia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the iron deficiency anemia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The iron deficiency anemia market includes revenues earned by entities by providing services such as iron supplementation, bone marrow biopsy, complete blood count (CBC), and blood tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Iron Deficiency Anemia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on iron deficiency anemia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for iron deficiency anemia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The iron deficiency anemia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Therapy Type: Oral Iron Therapy; Parenteral Iron Therapy; Red Blood Cell Transfusion
• 2) By Distribution Channel: Hospital Pharmacy; Drug Stores and Retail Pharmacies; Online Pharmacies
• 3) By End Users: Hospitals; Clinics; Home Healthcare
• Subsegments:
• 1) By Oral Iron Therapy: Ferrous Sulfate; Ferrous Gluconate; Ferrous Fumarate; Polysaccharide-Iron Complex; Carbonyl Iron
• 2) By Parenteral Iron Therapy: Iron Sucrose; Ferric Carboxymaltose; Iron Dextran; Ferumoxytol; Ferric Gluconate
• 3) By Red Blood Cell Transfusion: Leukocyte-Reduced Red Blood Cell Transfusion; Washed Red Blood Cell Transfusion; Irradiated Red Blood Cell Transfusion
• Companies Mentioned: AbbVie Inc.; Sanofi S.A.; Abbott Laboratories; Fresenius SE & Co. KGaA; Sandoz International GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Iron Deficiency Anemia Market Characteristics

3. Iron Deficiency Anemia Market Trends And Strategies

4. Iron Deficiency Anemia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Iron Deficiency Anemia Growth Analysis And Strategic Analysis Framework

• 5.1. Global Iron Deficiency Anemia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Iron Deficiency Anemia Market Growth Rate Analysis
• 5.4. Global Iron Deficiency Anemia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Iron Deficiency Anemia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Iron Deficiency Anemia Total Addressable Market (TAM)

6. Iron Deficiency Anemia Market Segmentation

• 6.1. Global Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Iron Therapy
• Parenteral Iron Therapy
• Red Blood Cell Transfusion
• 6.2. Global Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Drug Stores and Retail Pharmacies
• Online Pharmacies
• 6.3. Global Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Home Healthcare
• 6.4. Global Iron Deficiency Anemia Market, Sub-Segmentation Of Oral Iron Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ferrous Sulfate
• Ferrous Gluconate
• Ferrous Fumarate
• Polysaccharide-Iron Complex
• Carbonyl Iron
• 6.5. Global Iron Deficiency Anemia Market, Sub-Segmentation Of Parenteral Iron Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Iron Sucrose
• Ferric Carboxymaltose
• Iron Dextran
• Ferumoxytol
• Ferric Gluconate
• 6.6. Global Iron Deficiency Anemia Market, Sub-Segmentation Of Red Blood Cell Transfusion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leukocyte-Reduced Red Blood Cell Transfusion
• Washed Red Blood Cell Transfusion
• Irradiated Red Blood Cell Transfusion

7. Iron Deficiency Anemia Market Regional And Country Analysis

• 7.1. Global Iron Deficiency Anemia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Iron Deficiency Anemia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Iron Deficiency Anemia Market

• 8.1. Asia-Pacific Iron Deficiency Anemia Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Iron Deficiency Anemia Market

• 9.1. China Iron Deficiency Anemia Market Overview
• 9.2. China Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Iron Deficiency Anemia Market

• 10.1. India Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Iron Deficiency Anemia Market

• 11.1. Japan Iron Deficiency Anemia Market Overview
• 11.2. Japan Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Iron Deficiency Anemia Market

• 12.1. Australia Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Iron Deficiency Anemia Market

• 13.1. Indonesia Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Iron Deficiency Anemia Market

• 14.1. South Korea Iron Deficiency Anemia Market Overview
• 14.2. South Korea Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Iron Deficiency Anemia Market

• 15.1. Western Europe Iron Deficiency Anemia Market Overview
• 15.2. Western Europe Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Iron Deficiency Anemia Market

• 16.1. UK Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Iron Deficiency Anemia Market

• 17.1. Germany Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Iron Deficiency Anemia Market

• 18.1. France Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Iron Deficiency Anemia Market

• 19.1. Italy Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Iron Deficiency Anemia Market

• 20.1. Spain Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Iron Deficiency Anemia Market

• 21.1. Eastern Europe Iron Deficiency Anemia Market Overview
• 21.2. Eastern Europe Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Iron Deficiency Anemia Market

• 22.1. Russia Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Iron Deficiency Anemia Market

• 23.1. North America Iron Deficiency Anemia Market Overview
• 23.2. North America Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Iron Deficiency Anemia Market

• 24.1. USA Iron Deficiency Anemia Market Overview
• 24.2. USA Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Iron Deficiency Anemia Market

• 25.1. Canada Iron Deficiency Anemia Market Overview
• 25.2. Canada Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Iron Deficiency Anemia Market

• 26.1. South America Iron Deficiency Anemia Market Overview
• 26.2. South America Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Iron Deficiency Anemia Market

• 27.1. Brazil Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Iron Deficiency Anemia Market

• 28.1. Middle East Iron Deficiency Anemia Market Overview
• 28.2. Middle East Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Iron Deficiency Anemia Market

• 29.1. Africa Iron Deficiency Anemia Market Overview
• 29.2. Africa Iron Deficiency Anemia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Iron Deficiency Anemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Iron Deficiency Anemia Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Iron Deficiency Anemia Market Competitive Landscape And Company Profiles

• 30.1. Iron Deficiency Anemia Market Competitive Landscape
• 30.2. Iron Deficiency Anemia Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sandoz International GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Iron Deficiency Anemia Market Other Major And Innovative Companies

• 31.1. CSL Limited
• 31.2. Daiichi Sankyo Company Limited
• 31.3. Perrigo Company
• 31.4. Cipla Limited
• 31.5. Dr. Reddy's Laboratories Limited
• 31.6. Cadila Healthcare Limited
• 31.7. Zydus Cadila
• 31.8. Lupin Limited
• 31.9. Alkem Laboratories Limited
• 31.10. AMAG Pharmaceuticals Inc.
• 31.11. Akebia Therapeutics Inc.
• 31.12. Rockwell Medical Inc.
• 31.13. Pharmacosmos A/S
• 31.14. Shield Therapeutics plc
• 31.15. AdvaCare Pharma LLC

32. Global Iron Deficiency Anemia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Iron Deficiency Anemia Market

34. Recent Developments In The Iron Deficiency Anemia Market

35. Iron Deficiency Anemia Market High Potential Countries, Segments and Strategies

• 35.1 Iron Deficiency Anemia Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Iron Deficiency Anemia Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Iron Deficiency Anemia Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료